WP
ONCE

WMS Partners’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

WMS Partners’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-6,000
Closed -$272K – 211
2015
Q4 		$272K Hold
6,000
– – 0.04% 168
2015
Q3 		$250K Buy
+6,000
New +$313K 0.04% 173

Other funds holding ONCE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

WMS Partners's ONCE Position: Q1 2016 in Review

WMS Partners sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q1 2016, closing a stake of 6,000 shares — an estimated $272K sold.

WMS Partners first reported a position in ONCE in Q3 2015 and held it in 2 quarters. The position peaked at $272K in Q4 2015. 105 funds tracked by Wall St. Rank hold ONCE as of Q1 2016.

  • WMS Partners reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q1 2016 after selling out during the quarter.
  • WMS Partners sold 6,000 Spark Therapeutics, Inc. Common Stock shares in Q1 2016, an estimated $272K.
  • WMS Partners first reported a position in Spark Therapeutics, Inc. Common Stock in Q3 2015 and held it in 2 quarters.
  • WMS Partners's Spark Therapeutics, Inc. Common Stock position peaked at $272K in Q4 2015.
  • 105 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q1 2016.

Based on WMS Partners's 13F filing for Q1 2016, filed 11 May 2016.